Form 4: Intuitive Surgical CFO's Routine Stock Transactions

Intuitive Surgical's EVP & CFO, Jamie Samath, reported multiple transactions involving common stock, Restricted Stock Units (RSUs), and Performance Stock Units (PSUs) on February 26, 2026.

Summary

• Jamie Samath, Executive Vice President & Chief Financial Officer and Head of Enterprise Technology at Intuitive Surgical Inc. (ISRG), reported several transactions on February 26, 2026.
• Samath acquired 1,908 shares of common stock through the exercise of Restricted Stock Units (RSUs) at a price of $0.0.
• Subsequently, 900 shares of common stock were disposed of at a price of $506.17 to cover statutory tax withholding requirements.
• An additional 1,488 shares of common stock were acquired through the exercise of RSUs at a price of $0.0.
• Following this, 738 shares of common stock were disposed of at a price of $506.17 for statutory tax withholding.
• Samath also acquired 3,591 Performance Stock Units (PSUs) which vested on February 28, 2026, after achieving certain performance metrics.
• A new grant of 6,720 Restricted Stock Units (RSUs) was reported, vesting 25% annually over a four-year period, commencing on the first anniversary of the grant date of February 26, 2026.
• After all reported transactions, Samath's direct beneficial ownership of common stock stands at 9,557 shares, with additional derivative holdings of 10,773 PSUs and 6,720 RSUs.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine filing reflecting the vesting of previously granted equity awards and subsequent tax-related sales, indicating ongoing executive compensation and a stable compensation structure.

Positives

• The vesting of 3,591 Performance Stock Units (PSUs) indicates the achievement of specific performance criteria set by the Compensation Committee.
• The acquisition of 1,908 and 1,488 shares of common stock from RSU exercises, and a new grant of 6,720 RSUs, reflects ongoing executive compensation and alignment with shareholder interests.

Negatives

• The disposal of 900 and 738 shares of common stock, totaling 1,638 shares, was executed to cover statutory tax withholding requirements, which is a routine event but represents a reduction in direct share ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transaction filings like Form 4 provide transparency into executive compensation and ownership changes, which can be a signal for investor sentiment, though these specific transactions are routine equity award vestings and tax-related sales. Such filings are common across the medical device and technology sectors, reflecting standard executive compensation structures.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and ownership, confirming that executive incentives are tied to company performance through equity awards.
• Employees: Reflects standard equity compensation practices for executives, which can set a precedent for broader employee incentive programs.

Next Steps

• The newly granted Restricted Stock Units (RSUs) will vest 25% annually over a four-year period, commencing on the first anniversary of the February 26, 2026 grant date.

Key Dates

Recommendation

The filing details routine insider transactions related to the vesting of equity awards and subsequent tax-related sales. It does not provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. These are expected compensation events.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Performance Stock Units, Stock Vesting, Tax Withholding, Jamie Samath